Financials

  • Market Capitalization 27.28 B
  • Employee 1 664
  • Founded 1988
  • CEO William H. Lewis
  • Website www.insmed.com
  • Headquarter Virginia, United States
  • FIGI BBG000BWM5P3
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-25.88
ratio cours/chiffre d'affaires
19.83

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
409
ALNY
Alnylam Pharmaceuticals, Inc. - Common Stock
260.09 USD-2.26%+5.68%+19.31%-43.46%34.80 B USD
448
ROIV
Roivant Sciences Ltd. - Common Shares
41.48 USD+18.75%+20.09%+15.51%+126.54%29.96 B USD
485
RPRX
Royalty Pharma plc - Class A Ordinary Shares
60.59 USD-5.27%-2.78%+5.50%+62.61%27.06 B USD
509
INCY
Incyte Corporation - Common Stock
124.40 USD-1.85%-0.49%+3.19%+44.00%25.22 B USD

Nouvelles